U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06939751) titled 'OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels (Optimal)' on April 15.
Brief Summary: This study aims to develop and refine a miR biomarker panel that can be used to phenotype net immune state after heart transplantation.
Study Start Date: June 03
Study Type: OBSERVATIONAL
Condition:
Cardiac Failure
Graft Rejection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Inova Health Care Services
Disclaimer: Curated by HT Syndication....